LBX Pharmacy Chain

603883

CNE1000023Q8

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
31.26 ^CNY	-0.29%		+1.49%	+4.58%

Mar. 07	Nomura Adjusts LBX Pharmacy Chain’s Price Target to 45.79 Yuan From 43.96 Yuan, Keeps at Buy	MT
2023	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Laobaixing Pharmacy Chain Joint Stock Company announced that it expects to receive CNY 800 million in funding from Hunan Laobaixing Medicine Investment Management Ltd.

September 28, 2016

Laobaixing Pharmacy Chain Joint Stock Company (SHSE:603883) announced that it will receive CNY 800,000,000 in equity round of funding on September 29, 2016. The transaction was approved at the 28th session of the 2nd directorate of the company.

Latest news about LBX Pharmacy Chain

Nomura Adjusts LBX Pharmacy Chain’s Price Target to 45.79 Yuan From 43.96 Yuan, Keeps at Buy	Mar. 07	MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-31	CI
Nomura Adjusts LBX Pharmacy Chain's Price Target to 43.96 Yuan From 44.28 Yuan, Keeps at Buy	23-10-31	MT
LBX Pharmacy Chain Joint Stock Company agreed to acquire 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. from Chen Jinxi for CNY210 million.	23-10-29	CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Nomura Adjusts LBX Pharmacy's Price Target to 44.28 Yuan From 42.20 Yuan, Keeps at Buy	23-08-07	MT
Bank of Qinghai Gets New Majority Shareholder	23-07-27	MT
Nomura Starts LBX Pharmacy Chain at Buy With 42.2 Yuan Price Target	23-05-18	MT
China recovery looms large at Sohn 2023 hedge fund conference	23-05-18	RE
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Hello Group Chief Executive Li Wang Resigns	22-10-28	MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
UBS Adjusts LBX Pharmacy Chain's Price Target to 40 Yuan From 36.5 Yuan, Keeps at Buy	22-08-31	MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Chairman to Boost Shanghai Bio-heart Stake	22-08-07	MT
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online	22-06-22	MT
UBS Adjusts LBX Pharmacy Chain's Price Target to 47.50 Yuan From 81.50 Yuan, Keeps at Buy	22-05-27	MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a 71.9% stake in Hunan Huairen Great Health Industry Development Co., Ltd. from group of sellers for CNY 1.6 billion.	22-03-06	CI
LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong.	22-03-05	CI
LBX Pharmacy Chain Joint Stock Company announced that it has received CNY 1.740453674 billion in funding from a group of investors	22-01-26	CI
LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. from Cui Xufang and Xu Yuping.	21-11-14	CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI

Chart LBX Pharmacy Chain

Duration

Period

More charts

Company Profile

LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.

Sector

Drug Retailers

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for LBX Pharmacy Chain

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

31.26 CNY

Average target price

39.28 CNY

Spread / Average Target

+25.66%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs with Grocery

	1st Jan change	Capi.
LBX PHARMACY CHAIN	+4.58%	2.53B
COSMOS PHARMACEUTICAL CORPORATION	-9.21%	3.67B
SUNDRUG CO.,LTD.	-1.96%	3.34B
TSURUHA HOLDINGS INC.	-21.35%	3.18B
SUGI HOLDINGS CO.,LTD.	+9.43%	2.8B
KUSURI NO AOKI HOLDINGS CO., LTD.	-11.10%	1.68B
CREATE SD HOLDINGS CO., LTD.	+10.93%	1.39B
GREAT TREE PHARMACY CO., LTD.	-19.03%	981M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-40.19%	684M
FARMACIAS BENAVIDES, S.A.B. DE C.V.	-0.53%	455M

Retail - Drugs with Grocery

LBX Pharmacy Chain

Equities

603883

CNE1000023Q8

Drug Retailers

Laobaixing Pharmacy Chain Joint Stock Company announced that it expects to receive CNY 800 million in funding from Hunan Laobaixing Medicine Investment Management Ltd.

EPS Revisions